Brevan Howard Capital Management’s Elevance Health ELV Stock Holding History

Brevan Howard Capital Management’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$4.9M	Buy	+16,728	New	+$5.5M	0.04%	235
2025 Q4	–	Sell	-11,874	Closed	-$3.84M	–	1926
2025 Q3	$3.84M	Sell	11,874 -23,597	-67%	-$7.34M	0.02%	310
2025 Q2	$13.8M	Buy	+35,471	New	+$14.3M	0.08%	128
2025 Q1	–	Sell	-5,548	Closed	-$2.05M	–	1243
2024 Q4	$2.05M	Buy	5,548 +2,568	+86%	+$1.07M	0.01%	280
2024 Q3	$1.55M	Sell	2,980 -7,485	-72%	-$4M	0.01%	324
2024 Q2	$5.67M	Buy	10,465 +7,514	+255%	+$3.97M	0.05%	84
2024 Q1	$1.53M	Buy	2,951 +2,181	+283%	+$1.08M	0.01%	187
2023 Q4	$363K	Buy	+770	New	+$356K	﹤0.01%	631

Other funds holding ELV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Brevan Howard Capital Management's ELV Position: Q1 2026 in Review

Brevan Howard Capital Management opened a new position in Elevance Health (ELV) in Q1 2026: 16,728 shares worth $4.9M. The stake represents 0.04% of the portfolio and ranks #235 among its holdings. This is a return to the name: Brevan Howard Capital Management previously reported a position in ELV as recently as Q3 2025.

Brevan Howard Capital Management first reported a position in ELV in Q4 2023 and has held it in 8 quarters since. The position peaked at $13.8M in Q2 2025. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

Brevan Howard Capital Management held 16,728 shares of Elevance Health worth $4.9M as of Q1 2026.
Elevance Health was a new Brevan Howard Capital Management position in Q1 2026.
Elevance Health made up 0.04% of Brevan Howard Capital Management's portfolio in Q1 2026, its #235 holding.
Brevan Howard Capital Management first reported a position in Elevance Health in Q4 2023 and has held it in 8 quarters since.
Brevan Howard Capital Management's Elevance Health position peaked at $13.8M in Q2 2025.
1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Brevan Howard Capital Management's 13F filing for Q1 2026, filed 15 May 2026.